1. Home
  2. ROIV vs TSN Comparison

ROIV vs TSN Comparison

Compare ROIV & TSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$29.34

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$66.81

Market Cap

21.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
TSN
Founded
2014
1935
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
21.6B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
ROIV
TSN
Price
$29.34
$66.81
Analyst Decision
Strong Buy
Buy
Analyst Count
9
10
Target Price
$28.94
$66.90
AVG Volume (30 Days)
4.4M
2.5M
Earning Date
05-28-2026
05-04-2026
Dividend Yield
N/A
3.21%
EPS Growth
N/A
N/A
EPS
N/A
0.97
Revenue
$29,053,000.00
$54,441,000,000.00
Revenue This Year
N/A
$5.74
Revenue Next Year
$744.61
$1.14
P/E Ratio
N/A
$69.52
Revenue Growth
N/A
2.12
52 Week Low
$10.58
$50.56
52 Week High
$30.33
$69.48

Technical Indicators

Market Signals
Indicator
ROIV
TSN
Relative Strength Index (RSI) 59.02 55.60
Support Level $27.00 $62.25
Resistance Level $30.26 $69.48
Average True Range (ATR) 0.87 2.05
MACD 0.09 0.11
Stochastic Oscillator 85.95 63.09

Price Performance

Historical Comparison
ROIV
TSN

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

Share on Social Networks: